Q1,Q2,Q3,Q4,Q5,Q6,Q7,Q8,Q9,Q10,Q11,Q12,Q13,Q14,Q15,Q16,Q17,Q18,Q19,Q20,Q21,Q22,Q23,Q24,Q25,Q26,Q27,Q28,Q29,Q30,Q31,Q32,Q33,Q34,Q35,Q36,Q37,Q38,Q39,Q40,Q41,Q42,Q43,Q44,Q45,Q46,Q47,Q48,Q49,Q50,Q51,Q52,Q53,Q54,Q55,Q56,Q57,Q58,Q59,Q60,Q61,Q62,Q63,Q64,Q65,Q66,Q67,Q68,Q69,Q70,Q71,Q72,Q73,Q74,Q75,Q76
1,2,1,1,2,1,"Version 2 does not make comment on the preference to give amiodarone via central venous access device when repeated doses or continuous infusions are used which I think is quite important as extravasation risk increase the more frequently and longer you give it. The wording ""extreme clinical emergency"" in version 1 is stronger than ""unless clinical situation is dire""- the latter may result in it being given peripherally in more cases as most patients requiring IV amiodarone are already on a more monitored high dependency bed. Similarly if you use the phrase ""typically"" there can be a temptation for the user to think their patient isn't ""typical"". Stating what is common practice is more neutral, and may be more likely to be followed.",4,2,,,,,,2,,,,,,1,2,2,1,"Version 2 does not state which concentration will be achieved or how much glucose 5% to add the amiodarone to, so it repeats itself and may result in higher or lower concentrations being administered for any of the loading doses, maintenance doses or IV injection. This makes this section far less useful for version 2.",1,1,1,1,1,,3,1,1,1,1,,3,1,1,1,1,,4,1,1,1,1,"Wording is slightly different, I prefer version 1 where it leads with giving via a central venous access device",3,2,,,,,,1,1,1,1,,3,1,2,2,1,"Version 2 does not list any of the compatible/incompatible drugs, it just simply states ""list of incompatible/compatible drugs""",1,2,,,,,,2,
1,3,1,2,2,1,Version 2 omits dilution instructions for peripheral administration of amoxicillin. Given the high proportion of giving amoxicillin IV peripherally compared with central access this is a key piece of information that most nurses would want to read,2,1,2,2,1,"Doesn't state the final concentration in the 500mg vial section. I can see it says ""to make the same solution"" instead but this will often get misunderstood or not read when nurses make up large numbers of drugs. Best to be clear and succinct what you add in and what the final concentration will be. Bullet points make version 2 easier to read however",3,2,,,,,,1,2,2,1,"Version 2 doesn't mention about mini -bags or burettes. Burettes are now less commonly used with computerised pumps delivering controlled rates are the mainstay, minibags are implied by the suggested volume. Nurses and other HCPs who are more recently qualified may be confused by the mention of burettes so it makes version 1 less clear.",4,2,,,,,,1,1,1,1,,3,1,2,1,2,"Version 2 states ""expect convulsions in those with renal impairment or high doses"". This would be quite alarming to nurses administering it, and this risk should be mitigated by prescribers and pharmacists adjusting doses. Wording in version 1 is better, these events can occur but we're not expecting them to in a large number of cases",2,1,1,1,1,,3,2,,,,,,1,2,2,2,"Version 2 omits information about a Bowmed Ibisqus brand not fitting enough WFI inside. However the affected batches expired 8 years ago so this should be intentionally removed now. It does however offer a more general comment that vial sizes and manufacturer reconstitution instructions vary and to check each individual manufacturer. This more general comment is better in version 2, however it does go against it's recommendations in the reconstitution section.",5,1,2,2,1,"Version 2 states ""do not infuse with any other medications"", this point is in both but version 1 states not to administer the injection via a line being used for an infusion. This is a subtle difference but it is an omission in version 2. Layout in version 2 is easier to read",3,1,1,1,1,,3,4,"Layout is improved, removes information that is out of date about a specific brand that should not have been in use for 8 years. Some slight omissions in information but overall was slightly easier to understand"
1,4,1,1,1,1,"Combines guidelines that are actually two separate links, no clinical changes. Better readability in version 2",4,1,1,1,1,,4,1,1,1,1,,4,1,1,1,1,,3,2,,,,,,1,1,1,1,,3,1,1,1,1,,4,1,1,1,1,,3,2,,,,,,1,1,1,1,,3,1,1,1,1,,5,2,,,,,,4,More spacing in the formatting breaks up the text and makes each individual point easier to read.
3,4,1,1,1,1,,2,1,1,1,1,,5,1,1,1,1,,2,1,1,1,1,,4,2,,,,,,1,1,1,1,,3,1,1,1,1,,4,1,1,1,1,,5,2,,,,,,1,1,1,1,,4,1,1,1,1,,5,2,,,,,,5,"First monograph reviewed in this project. I prefer the bullet point nature of the incompatibilities. 'For guidance, please refer to X' reads better than having a link to a guideline. I think the back-to-back comment is very difficult to read in version two as I read bullet points as stepwise approach to things whereas the second bullet point in this section on version 2 should be another sentence at the end of bullet point 1"
3,6,1,1,1,1,,4,2,,,,,,2,,,,,,1,1,1,1,,2,1,1,1,1,,2,1,1,1,1,,3,1,1,1,1,,4,1,1,1,1,,3,2,,,,,,1,1,1,1,,4,1,1,2,1,"Some of the Thames Valley compatibility is omitted from Version 2 (it states ""and so on"")",5,2,,,,,,4,"I think some of the wording is easier to understand and I find compatibilities easier as a bullet point format (particulary splitting glucose 5% and sodium chloride 0.9%). Version 1 has its benefits being blunt with ""24hours"" which is quicker than reading a sentence "
3,7,1,1,1,1,,3,1,1,1,1,,3,2,,,,,,1,1,1,1,,4,2,,,,,,1,1,1,1,,3,1,1,1,1,,4,1,1,1,1,,3,2,,,,,,1,1,1,1,,4,1,1,1,1,,4,2,,,,,,4,"I think that the layout in bullet point is easier to read. I am not sure about glucose in V2 as it is referred as 5% glucose, not glucose 5%. Also it advises ""Doctors do not use..."" to an audience that probably won't use the monograph as frequently. "
2,1,1,2,1,1,,3,2,,,,,,2,,,,,,1,1,1,1,,3,1,1,1,1,,3,1,1,1,1,,3,1,2,2,2,"Version 1 - hypotension, version 2 - hypertension",4,1,1,1,1,,2,1,1,1,1,,3,2,,,,,,1,1,1,1,,4,2,,,,,,4,Layout - bullet point list makes it easier to read
2,2,1,1,1,1,,4,2,,,,,,2,,,,,,1,2,2,1,Version 1 suggests end concentrations (e.g. 300mg/50ml) and the quantities of glucose 5% to add. This is missing in version 2. This could mean that different end concentrations are used depending on which monograph is followed.,2,1,1,1,1,,3,1,1,1,1,,3,1,1,1,1,,4,1,1,1,1,,3,2,,,,,,1,1,1,1,,3,1,2,2,1,No list of compatible or incompatible drugs in version 2.,1,2,,,,,,3,"Layout - bullet point list is easier to read. However, no list of compatible drugs and dilution section is ambiguous."
2,3,1,1,2,1,Version 2 misses instruction about diluting in 100ml sodium chloride 0.9%,4,1,1,1,1,,3,2,,,,,,1,1,2,1,Version 2 misses the comment about using a mini-bag or in line burette.,3,2,,,,,,1,1,1,1,,3,1,1,1,1,,4,1,1,1,1,,2,2,,,,,,1,1,2,1,Version 2 misses instructions for Bowmed brand,4,1,1,1,1,,5,1,1,1,1,,4,4,More concise language and use of bullet points
2,4,1,1,1,1,,4,1,1,2,1,Version 1 includes adding a 2g dose to 50mL or a 2g or 4g dose to 100mL sodium chloride 0.9% or glucose 5%. This is missing in version 2.,4,1,1,1,1,,4,1,1,1,1,,3,2,,,,,,1,1,1,1,,4,1,1,1,1,,4,1,1,1,1,,5,2,,,,,,1,1,1,1,,4,1,1,1,1,,4,2,,,,,,4,"More "
2,5,1,1,1,1,,4,2,,,,,,2,,,,,,1,1,1,1,,3,2,,,,,,1,1,1,1,,3,1,1,1,1,,4,1,1,1,1,,2,2,,,,,,1,1,1,1,,3,1,1,1,1,,4,2,,,,,,4,More concise language and use of bullet points
2,6,1,1,1,1,,4,2,,,,,,2,,,,,,1,1,1,1,,2,1,1,1,1,,3,1,1,1,1,,3,1,1,1,1,,4,1,1,1,1,,3,1,1,1,1,,2,1,1,1,1,,4,1,1,2,1,Comprehensive list of Thames Valley site IV compatible drugs is missing in Version 2.,4,2,,,,,,4,More concise language and use of bullet points. Space between drugs that are compatible and incompatible.
2,7,1,1,1,1,,4,1,1,1,1,,3,2,,,,,,1,1,1,1,,3,2,,,,,,1,1,1,1,,3,1,1,1,1,,3,1,1,1,1,,3,2,,,,,,1,1,1,1,,3,1,1,1,1,,4,2,,,,,,3,
3,10,1,1,1,1,,1,2,,,,,,2,,,,,,1,1,1,1,,3,2,,,,,,1,1,1,1,,3,1,1,1,1,,4,1,1,1,1,,3,2,,,,,,1,1,1,1,,3,1,1,1,1,,4,2,,,,,,3,I like version 2 however I do not think giving 'over a span of 15minutes' is clear guidance
2,8,1,1,1,1,,4,2,,,,,,2,,,,,,1,1,1,1,,4,1,1,1,1,,3,1,1,1,1,,3,1,1,1,1,,4,1,1,2,1,There is not extravasation section in Version 2 but the relevant information is under Adverse effects,2,1,1,1,1,,4,1,1,1,1,,4,1,1,1,1,,4,2,,,,,,4,
2,9,1,1,1,1,,3,2,,,,,,2,,,,,,1,1,1,1,,3,2,,,,,,1,1,1,1,,2,1,1,1,1,,4,1,1,1,1,,2,2,,,,,,1,1,1,1,,4,1,1,1,1,,4,2,,,,,,4,
2,10,1,1,1,1,,3,2,,,,,,2,,,,,,1,1,1,1,,3,2,,,,,,1,1,1,1,,3,1,1,1,1,,4,1,1,1,1,,3,2,,,,,,1,1,1,1,,4,1,1,1,1,,4,2,,,,,,3,
2,11,1,1,1,1,,2,2,,,,,,2,,,,,,1,1,1,1,,4,1,1,1,1,,3,1,1,1,1,,3,1,1,1,1,,4,1,1,1,1,,3,2,,,,,,1,1,1,1,,3,1,1,1,1,,4,2,,,,,,4,Layout - bullet point list makes it easier to read
3,9,1,1,1,1,,4,2,,,,,,2,,,,,,1,1,1,1,,4,2,,,,,,1,1,1,1,,4,1,1,1,1,,4,1,1,1,1,,3,2,,,,,,2,,,,,,1,1,1,1,,5,2,,,,,,4,"This is a very wordy monograph, particularly the list of compatibilities. I find a list much easier to read. The once daily dose unlicensed section is confusing for both monographs but v2 is slightly more comprehensible"
3,5,1,1,1,1,,4,2,,,,,,2,,,,,,1,1,1,1,,4,2,,,,,,2,,,,,,1,1,1,1,,4,1,1,1,1,,3,2,,,,,,1,1,1,1,,3,1,1,1,1,,3,2,,,,,,4,I found the unlicensed section difficult to read. I am assuming on v1 that using sodium chloride 0.9% is unlic whereas the v2 makes it sounds like all three diluents are unlic
3,8,1,1,2,1,"IV injection and IV infusion specifices a cut off of 442micromol/L in v1, but not for infusion in V2. V2 also abbreiviates micromol ",4,2,,,,,,2,,,,,,1,1,1,1,,4,1,1,1,1,,3,1,1,1,1,,3,1,1,1,1,,2,2,,,,,,1,1,2,1,example 2 missed in version 2. The calculation is much easier to interpret using version 1,1,1,1,1,1,,5,1,1,1,1,,4,2,,,,,,4,"V2 has glucose as an incompatibility as part of the list, whereas predominant in v1. "
2,12,1,1,1,1,,3,1,1,1,1,,2,2,,,,,,1,1,2,1,Version 2 suggests no specific volumes for doses up to 2g whereas Version 1 suggests 100ml.,2,2,,,,,,1,1,1,1,,3,1,1,1,1,,2,1,1,1,1,,3,2,,,,,,1,1,1,1,,3,1,1,1,1,,4,2,,,,,,3,
2,13,1,1,1,1,,3,2,,,,,,2,,,,,,2,,,,,,2,,,,,,1,1,1,1,,3,1,1,1,1,,3,1,1,1,1,,3,2,,,,,,1,1,1,1,,3,1,1,1,1,,3,2,,,,,,3,
2,14,1,1,1,1,,3,2,,,,,,2,,,,,,1,1,1,1,,3,1,1,1,1,,3,1,1,1,1,,3,1,1,1,1,,4,1,1,1,1,,3,1,2,1,1,The example calculation in Version 2 is inappropriately laid out as the 80micrograms/ml should be underneath the 0.1mcg/kg/min x 70kg x 60 minutes.,1,1,1,1,1,,3,1,1,2,1,Version 2 does not contain information about compatibility from Thames Valley Y-site IV drug compatibility chart,3,2,,,,,,2,
2,15,1,1,1,1,,3,1,1,1,1,,3,2,,,,,,1,2,2,1,"Under the IV infusion for major peptic ulcer bleeding, Version 1 states a concentration of 40mg/100ml or 80mg/100ml. Version 2 only states a concentration of 40mg or 80mg.",2,1,1,1,1,,3,1,1,1,1,,3,1,1,1,1,,4,1,1,1,1,,3,2,,,,,,1,1,1,1,,3,1,1,2,1,"Version 2 is missing the sentence ""Do not infuse with any other medicines or infusion fluids (other than those stated above)."" from Version 1.""",3,2,,,,,,3,
3,12,1,1,1,1,,5,1,1,1,1,,5,2,,,,,,1,1,1,1,,5,2,,,,,,1,1,1,1,,3,1,1,1,1,,4,1,1,1,1,,3,2,,,,,,1,1,1,1,,4,1,1,1,1,,3,2,,,,,,4,"I think that the layout in bullet point is easier to read. In adverse effects I probably would not have changed the work remedy to treatment however. "
3,11,1,1,1,1,,2,2,,,,,,2,,,,,,1,1,1,1,,3,1,1,1,1,,3,1,1,1,1,,3,1,1,1,1,,4,1,1,1,1,,3,2,,,,,,1,1,1,1,,3,1,1,1,1,,4,2,,,,,,2,"This is a difficult monograph. I think v2 refers as 'slow heart rate' instead of clinical term 'bradycardia'. The first sentence in v2 where One gram = 4mmol, i feel should say 1g = 4mmol (replacing number with word). Instructions for dilution on both monographs could be clearer and in numeric concentration order (5%, 10%, 20% and 50%)."
3,14,1,1,1,1,,4,2,,,,,,2,,,,,,1,1,1,1,,4,1,1,1,1,,3,1,1,1,1,,3,1,1,1,1,,4,1,1,1,1,,3,1,1,1,1,,1,2,,,,,,1,1,1,1,,4,2,,,,,,2,"I think the calculation in v2 is very difficult to follow as it is not in a 'formula' version, it has a new line instead of a division line. I am not sure why V2 has speechmarks in the adverse effects section. "
3,13,1,1,1,1,,4,2,,,,,,2,,,,,,2,,,,,,2,,,,,,1,1,1,1,,3,1,1,1,1,,3,1,1,1,1,,3,2,,,,,,1,1,1,1,,3,1,2,1,1,For piperacillin/tazobactam it add 'in tandem with tazobactam' however I feel V1 is explicit with avoiding disodium etate whereas V2 reads as preferable,2,2,,,,,,3,
3,15,1,1,1,1,,4,1,1,2,1,"Version 1 states to use the 100mL bag but whether that is significant in clinical practice, I am not too sure",3,2,,,,,,1,1,2,1,Version 2 states 40mg or 80mg dilutions are prepared but no volume given,2,1,1,1,1,,3,1,1,1,1,,3,1,1,1,1,,3,1,1,1,1,,3,2,,,,,,1,1,1,1,,3,1,1,1,1,,3,2,,,,,,2,
3,16,1,1,1,1,,3,2,,,,,,2,,,,,,2,,,,,,2,,,,,,1,1,1,1,,3,1,1,1,1,,3,1,1,1,1,,3,2,,,,,,1,1,1,1,,3,1,1,1,1,,3,2,,,,,,3,Both versions are quite straightforward however V2 omits lots of the technical information which may be clinically useful
2,16,1,1,1,1,,3,2,,,,,,2,,,,,,2,,,,,,2,,,,,,1,1,1,1,,3,1,1,1,1,,3,1,1,1,1,,3,2,,,,,,1,1,1,1,,3,1,1,1,1,,3,2,,,,,,3,
2,17,1,1,1,1,,4,2,,,,,,2,,,,,,1,1,1,1,,3,2,,,,,,1,1,1,1,,4,1,1,1,1,,4,2,,,,,,2,,,,,,1,1,2,1,Other comments section in Version 1 not present in Version 2,1,1,1,1,1,,4,2,,,,,,2,Version 2 missing the comments section
2,18,1,1,1,1,,3,1,1,1,1,,3,2,,,,,,1,1,1,1,,3,2,,,,,,1,1,1,1,,3,1,1,1,1,,4,1,1,1,1,,3,2,,,,,,1,1,2,1,,3,1,1,1,1,,3,2,,,,,,3,
3,17,1,1,1,1,,3,2,,,,,,2,,,,,,1,1,1,1,,3,2,,,,,,1,1,1,1,,3,1,1,1,2,"I am not sure if colleagues would interpret TDM mandatory and required slightly differently ",2,2,,,,,,2,,,,,,1,1,2,1,Other comments section is omitted from version 2,3,1,1,1,1,,3,2,,,,,,3,"Again, with adverse effects I prefer the list however I find both of these monographs straightforward to interpret "
2,19,1,1,1,1,,4,2,,,,,,2,,,,,,1,1,1,1,,3,1,1,1,1,,3,1,1,1,1,,3,1,1,1,1,,4,1,1,1,1,,3,2,,,,,,1,1,1,1,,3,1,1,2,1,"Version 1 adds ""Dexmedetomidine, Dobutamine, Dopamine, Esmolol, Fentanyl, Furosemide, Glyceryl Trinitrate (GTN), Heparin (Sodium), Insulin (Soluble), Ketamine, Labetalol, Magnesium Sulphate, Mannitol, Midazolam, Milrinone, Morphine, Noradrenaline, Potassium Chloride, Remifentanil, Sodium Chloride 0.9%, Sodium Nitroprusside (light protected), Thiopental Sodium, Vecuronium"" as compatible at Y-site. ",2,2,,,,,,4,
2,22,1,1,1,1,,3,1,1,1,1,,3,2,,,,,,1,1,1,1,,4,2,,,,,,1,1,1,1,,3,1,1,1,1,,4,1,1,1,1,,3,2,,,,,,1,1,1,1,,3,1,1,2,1,Version 1 includes glucose 5% and sodium chloride 0.45% which is not included in Version 2,2,1,1,1,1,,3,3,
2,20,1,1,1,1,,3,1,1,2,1,"Version 2 is missing ""do not shake"" from the instructions.",2,2,,,,,,1,1,1,1,,2,2,,,,,,1,1,1,1,,3,1,1,1,1,,3,1,1,1,1,,3,2,,,,,,1,1,2,1,Version 1 specifies that the infusion must be used in neonates. It also states that doses >800mg should be administered as an infusion. This is not included in Version 2.,3,1,1,1,1,,3,2,,,,,,2,
2,21,1,1,1,1,,3,1,1,2,1,"Version 1 includes 20ml to a 1g vial which is missing in Version 2. ",2,1,1,1,1,,3,1,1,1,1,,3,1,1,1,1,,3,1,1,1,1,,3,1,1,1,1,,3,2,,,,,,2,,,,,,1,1,2,1,Version 2 does not include the other comments section.,1,1,1,1,1,,3,2,,,,,,3,
3,18,1,1,1,1,,3,1,1,1,1,,3,2,,,,,,1,1,1,1,,3,2,,,,,,1,1,1,1,,3,1,1,1,1,,3,1,1,1,1,,3,2,,,,,,1,1,1,1,,3,1,1,1,1,,3,2,,,,,,3,
3,19,1,1,2,1,"I would consider the sentence on the last bullet point refers to both concentrations of propofol however in V2 it appears to be only relevant for propofol 2%, so I suspect this is a formatting error",2,2,,,,,,2,,,,,,1,1,1,1,,3,1,1,1,1,,3,1,1,1,1,,3,1,1,1,1,,4,1,1,1,1,,3,2,,,,,,1,1,1,1,,4,1,1,2,1,Omits a few drugs where compatibility is mentioned. I dont like the section in v2 with fluids as I think people would miss reading the 'Don't infuse or mix (...) section if going down a long list,4,2,,,,,,4,I prefer that side effects and suggested monitoring are split for V2
3,20,1,2,1,1,,3,1,1,2,1,"from practice, my understanding is not to shake a tecioplanin vial, and v2 omits this information",2,2,,,,,,1,1,1,1,,3,2,,,,,,1,1,1,1,,3,1,1,1,1,,4,1,1,1,1,,3,2,,,,,,1,1,2,1,Version 2 omits information for concentrations greater than 400mg. It also omits information about bolus dosing over 800mg (and to consider infusion),2,1,1,1,1,,3,2,,,,,,4,I like the list and layout of version 2 however I do have concerns about information that is missing. If I was reading in isolation (without knowing what is in V1) I think I would prefer V2
3,21,1,1,1,1,,5,1,1,2,1,"V2 omits what volume of WFI to add to vancomycin vials, and subsquently I feel it is not clear",1,1,1,1,1,,3,1,1,2,1,"For v2 the dilutions just say sodium chloride or glucose (it omits % concentration). I have put V2 is slightly easier to read, but if these had been correct I would say much easier ",4,1,1,1,1,,3,1,1,1,1,,3,1,1,1,1,,3,1,1,2,1,It is an unclear monograph as V1 has extravastation and V2 omits,1,2,,,,,,2,,,,,,1,1,1,1,,4,2,,,,,,4,"I prefer V2 as this is a big monograph with lots of content, and the list layout makes it easier to read. However there are issues with V2 like omitting % concs and dilution is not clear"
3,2,1,1,1,1,,2,2,,,,,,2,,,,,,1,1,2,1,Version 2 omits all the volumes and states add to glucose 5%. If the volumes were present it would be much easier to follow as it is less wordy,1,1,1,1,1,,3,1,1,1,1,,3,1,1,1,1,,3,1,1,1,1,,3,2,,,,,,1,1,1,1,,3,1,1,2,1,"all compatible/incompatible drugs are missed ",1,2,,,,,,1,"Due issues flagged, V1 is much easier to understand however the layout and appropriate corrections would make version 2 much better"
3,3,1,1,2,1,Version 2 omits information about using 100mL NaCl0.9% for peripheral route as a superior option,2,1,1,1,1,,4,2,,,,,,1,1,1,1,,4,2,,,,,,1,1,1,1,,3,1,1,1,2,"I would argue that there is a difference in v1 and v2 with convulsions. V1 suggest that a convulsion could occur whereas V2 states to expect - which is profoundly different ",2,1,1,1,1,,3,2,,,,,,1,1,2,1,"V2 omits some information about specific brands, but it does advise to refer to the SPC for this reason. I would argue in 2024 a warning from May2014 is no longer clinically warranted ",4,1,1,1,1,,4,2,,,,,,4,
3,1,1,1,1,2,V2 omits the section about venous irritation and to give via CVC. I would say that V2 is easier to understand but I know this section is omitted,4,2,,,,,,2,,,,,,1,1,2,1,V2 does not give clear concentrations for dilution compared to V1,2,1,1,1,1,,3,1,1,1,1,,3,1,1,1,1,,4,1,1,1,1,I dont like how the sentence is split in v2,2,1,1,1,1,I think the layout of V1 for calculating rate is much clearer than V2,2,1,1,2,1,V2 omits other comments,1,1,1,1,1,,4,2,,,,,,2,I prefer the lists of V2 however I dont think the calculation is easy to follow therefore I would opt for V1
3,22,1,1,1,1,,3,1,1,1,1,,2,2,,,,,,1,1,1,1,,3,2,,,,,,1,1,1,1,,3,1,1,1,1,,4,1,1,1,1,,3,2,,,,,,2,,,,,,1,1,1,1,,4,1,1,1,1,,3,4,"Version 2 is slightly easier due to the list formatting, especially with the adverse effects as it breaks down anaphylactoid into 2 sections. I was surprised that displacement was not in its own section but for this particular point, i think that V1 was easier to follow by making the displacement value clear as its own sentence, not incorporating into the dilution instruction sentence"
1,5,1,1,1,1,,3,2,,,,,,2,,,,,,1,1,2,1,Version 2 leaves out 5-10ml for WFI and saline entries. This is down to the way version 1 lists all three diluents and v2 puts them in separate bullet points,2,2,,,,,,1,1,1,1,,3,1,1,1,1,,4,1,1,1,1,,2,2,,,,,,1,1,1,1,,3,1,1,1,1,,3,2,,,,,,3,"Formatting on version 2 is slightly clearer, I prefer the wording in version 1 for methods of administration section to ""resite"" cannula rather than ""move"" cannula for version 2. "
1,6,1,1,1,1,,3,2,,,,,,2,,,,,,1,1,1,1,,3,1,1,1,1,,3,1,1,1,1,,3,1,1,1,1,,3,1,1,1,1,,3,2,,,,,,1,1,1,1,,3,1,2,2,1,"Version 2 does not list any of the compatible/incompatible drugs, it just simply states ""list of incompatible/compatible drugs""",1,2,,,,,,2,"Everything was very similar until compatibility section, the large omission of information in version 2 was too big to ignore."
1,7,1,1,1,1,,3,1,1,1,1,,3,2,,,,,,1,1,1,2,Placing the recommended dilution volume after the IV injection and IV infusion sections it becomes ambiguous which section it refers to.,2,2,,,,,,1,1,1,1,,3,1,1,1,1,,3,1,1,1,1,,3,2,,,,,,1,1,1,1,,3,1,1,1,1,,4,2,,,,,,3,"The dilution instructions for version 1 is better, as version 2 has a separate paragraph which makes the instructions slightly ambiguous. I prefer the compatibility section of version 2 for ease of understanding, but the grammar of the paragraph regarding blood products, lipid infusions needs correcting."
1,8,1,1,2,1,"For IV infusions, version 2 does not explicitly state to reduce rate to 2.5mg/min in severe renal impairment. This detail is likely to be missed.",2,2,,,,,,2,,,,,,1,1,1,1,,3,1,1,1,1,,3,1,1,1,1,,3,1,2,1,1,"The grouping of adverse effects in version 2 is less clear, doesn't make it as clear that many of these adverse effects have similar causes",2,1,1,1,1,,2,1,2,1,1,"Whilst not ""clinically relevant"" information, version 2 doesn't actually give any example calculations based on actual doses.",1,1,2,2,1,"Version 2 has lack of detail of administration times for 80mg, just says to give rapidly. Version 2 correctly removes very outdated information regarding discontinued products.",2,1,1,1,1,,4,2,,,,,,2,Administration and calculations sections easier to understand in v1. Version 2 layout of compatibility is slightly easier to understand.
1,9,1,2,1,1,Version 2 mixes up unlicensed administration and unlicensed products.,2,2,,,,,,2,,,,,,1,1,1,1,,3,2,,,,,,1,1,1,1,,4,1,2,1,1,"Version 2 makes the ""rarely"" and ""very rarely"" sections next to single adverse effects rather than a list like in version 1",2,1,1,1,1,,3,2,,,,,,1,1,1,1,,3,1,1,1,1,"Both contain the same error in the dopamine, furosemide compatibility information to contact pharmacy sentence at the end.",3,2,,,,,,2,"Only slight differences between the two, some mix up with using terms like ""unlicensed"" for products rather than unlicensed administration. Grouping of adverse effects wasn't clear which were rare or very rare in version 2. "
1,10,1,1,1,1,,3,2,,,,,,2,,,,,,1,1,1,1,,3,2,,,,,,1,1,1,1,,3,1,1,1,1,,3,1,1,1,1,,3,2,,,,,,1,1,1,1,,3,1,1,1,1,,3,2,,,,,,3,
4,1,1,1,1,1,,2,1,1,1,1,,3,2,,,,,,1,1,1,1,,3,1,1,1,1,,3,1,1,1,1,,3,1,1,1,1,,3,1,1,1,1,,3,1,1,1,1,,4,2,,,,,,2,,,,,,2,,,,,,4,"The layout for section 2 is better , better front as well "
4,11,1,1,1,1,,4,1,1,1,1,,4,2,,,,,,1,1,1,1,,3,1,1,1,2,The addition of the word ' write an expiry time of',5,1,1,1,1,,3,1,1,1,2,"wording has changed instead of bradycardia the words slow heart rate is used ",5,1,1,1,1,,3,2,,,,,,1,1,1,1,,3,1,1,1,1,,4,2,,,,,,4,"The layout and format is easier to understand "
4,12,1,1,1,1,,3,1,2,1,1,"The word shake is used in v1 , whereas the word swirl is used in v2 ",3,2,,,,,,1,1,1,1,,3,2,,,,,,1,1,1,1,,3,1,1,1,1,,3,1,1,1,1,,3,2,,,,,,1,1,1,1,,5,1,1,1,1,,5,2,,,,,,4,"use of layout and plain English "
4,13,1,1,1,1,,4,2,,,,,,2,,,,,,2,,,,,,2,,,,,,1,1,1,1,,3,1,1,1,1,,3,1,1,1,1,,3,2,,,,,,1,1,1,1,,3,1,1,1,1,,3,2,,,,,,4,Layout of the text makes it easier to read
4,14,1,1,1,1,,3,1,1,1,1,,3,2,,,,,,1,1,1,1,,3,1,1,1,1,,3,1,1,1,1,,3,1,1,1,1,,3,1,1,1,1,,3,1,1,1,1,,3,1,1,1,1,,3,1,1,1,1,,3,2,,,,,,4,
4,15,1,1,1,1,,3,1,1,1,1,,3,2,,,,,,2,,,,,,1,1,1,1,,3,1,1,1,1,,3,1,1,1,1,,3,1,1,1,1,,3,2,,,,,,1,1,1,1,,3,1,1,1,1,,4,2,,,,,,3,
4,16,1,1,1,1,,4,2,,,,,,2,,,,,,2,,,,,,2,,,,,,1,1,1,1,,3,1,1,1,1,,3,1,1,1,1,,3,2,,,,,,1,1,1,1,,3,1,1,1,1,,3,2,,,,,,3,
4,17,1,1,1,1,,4,1,1,1,1,,4,2,,,,,,1,1,1,1,,5,2,,,,,,1,1,1,1,,3,1,1,1,1,,4,2,,,,,,2,,,,,,2,,,,,,1,1,1,1,,3,2,,,,,,4,
4,18,1,1,1,1,,3,1,1,1,1,,3,2,,,,,,1,1,1,1,,3,2,,,,,,1,1,1,1,,3,1,1,1,1,,4,1,1,1,1,,3,2,,,,,,1,1,1,1,,3,1,1,1,1,,4,2,,,,,,3,
4,19,1,1,1,1,,3,2,,,,,,2,,,,,,1,1,1,1,,3,1,1,1,1,,3,1,1,1,1,,3,1,1,1,1,,3,1,1,1,1,,3,2,,,,,,1,2,2,2,,3,1,1,1,1,,3,2,,,,,,3,
4,20,1,1,1,1,,3,1,1,1,1,,3,2,,,,,,1,1,1,1,,3,1,1,1,1,,3,1,1,1,1,,3,1,1,1,1,,3,1,1,1,1,,3,2,,,,,,1,1,1,1,,3,1,1,1,1,,3,2,,,,,,3,
4,21,1,1,1,1,,3,1,1,1,1,,3,1,1,1,1,,3,1,1,1,1,,3,1,1,1,1,,3,1,1,1,1,,3,1,1,1,1,,4,1,1,1,1,,3,2,,,,,,1,1,2,1,"version 2  does not "" Store below 25oC in original packaging """,3,1,1,1,1,,4,2,,,,,,3,
4,22,1,1,1,1,,3,1,1,1,1,,3,2,,,,,,1,1,1,1,,3,2,,,,,,1,1,1,1,,3,1,1,1,1,,3,1,1,1,1,,3,2,,,,,,1,1,1,1,,3,1,1,1,1,,4,2,,,,,,3,